You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 8, February 24, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Use of Antiretroviral Therapy by Intravenous Drug Users With HIV

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Strathdee and colleagues1 identified patient and physician characteristics associated with antiretroviral therapy (ART) use in injection drug users (IDUs) infected with human immunodeficiency virus (HIV) and found that the odds of not receiving therapy were increased more than 3-fold for those not currently enrolled in drug or alcohol treatment programs. Unfortunately, they did not provide odds ratios (ORs) for enrollment in specific types of addiction treatment and in particular methadone maintenance programs. It would also be useful to know how physician experience in treating HIV illness correlates with physician authorization to prescribe methadone status.

John F. Anderson, MD
British Columbia Ministry of Health and Ministry
Responsible for Seniors
Victoria, British Columbia

1. Strathdee SA, Palepu A, Cornelisse PGA, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280:547-549. FREE FULL TEXT


To the Editor: Our experience in Harlem with the antiretroviral treatment of HIV-infected IDUs is quite different from that reported by Dr Celentano et al1 and by Dr Strathdee et al.2 These authors report ART . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Self-reported Antiretroviral Therapy in Injection Drug Users
David D. Celentano, David Vlahov, Sylvia Cohn, Vera M. Shadle, Olugbenga Obasanjo, and Richard D. Moore
JAMA. 1998;280(6):544-546.
ABSTRACT | FULL TEXT  

Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users
Steffanie A. Strathdee, Anita Palepu, Peter G. A. Cornelisse, Benita Yip, Michael V. O'Shaughnessy, Julio S. G. Montaner, Martin T. Schechter, and Robert S. Hogg
JAMA. 1998;280(6):547-549.
ABSTRACT | FULL TEXT  

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance
Mark A. Wainberg and Gerald Friedland
JAMA. 1998;279(24):1977-1983.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.